Literature DB >> 26088754

Mast cell production and response to IL-4 and IL-13.

Jamie J A McLeod1, Bianca Baker2, John J Ryan2.   

Abstract

IL-4 was identified as the first cytokine to be produced by mast cells and is responsible for promoting mast cell IL-13 production. IL-4 and IL-13 play a prominent role in stimulating and maintaining the allergic response. As closely related genes, IL-4 and IL-13 share a common receptor subunit, IL-4Rα, necessary for signaling. Here we summarize the literature on mast cell activation associated with IL-4 and IL-13 production, including downstream signaling. We also describe the positive and negative roles each cytokine plays in mast cell immunity and detail the differences that exist between mouse and human mast cell responses to IL-4 and IL-13.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-13; IL-4; Interleukin-13; Interleukin-4; Mast cells

Mesh:

Substances:

Year:  2015        PMID: 26088754      PMCID: PMC4532630          DOI: 10.1016/j.cyto.2015.05.019

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  84 in total

1.  IL-4 preferentially activates a novel STAT6 isoform in mast cells.

Authors:  M A Sherman; V H Secor; M A Brown
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

Review 2.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

Authors:  Stephen J Galli; Janet Kalesnikoff; Michele A Grimbaldeston; Adrian M Piliponsky; Cara M M Williams; Mindy Tsai
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.

Authors:  Zan Huang; John M Coleman; Yan Su; Meredith Mann; John Ryan; Leonard D Shultz; Hua Huang
Journal:  Cytokine       Date:  2004-12-01       Impact factor: 3.861

Review 4.  Integrated signalling pathways for mast-cell activation.

Authors:  Alasdair M Gilfillan; Christine Tkaczyk
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

5.  Identification and characterization of undifferentiated mast cells in mouse bone marrow.

Authors:  Maria Célia Jamur; Ana Cristina G Grodzki; Elsa H Berenstein; Majed M Hamawy; Reuben P Siraganian; Constance Oliver
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

6.  Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells.

Authors:  Gregorio Gomez; Claudia Gonzalez-Espinosa; Sandra Odom; Gabriela Baez; M Eugenia Cid; John J Ryan; Juan Rivera
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

7.  Early IL-4 production driving Th2 differentiation in a human in vivo allergic model is mast cell derived.

Authors:  M Wang; A Saxon; D Diaz-Sanchez
Journal:  Clin Immunol       Date:  1999-01       Impact factor: 3.969

8.  IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos.

Authors:  Axel Lorentz; Mikosch Wilke; Gernot Sellge; Hans Worthmann; Jürgen Klempnauer; Michael P Manns; Stephan C Bischoff
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

9.  Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production.

Authors:  André Gessner; Katja Mohrs; Markus Mohrs
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

10.  Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion.

Authors:  L Andrew Bouton; Carlos D Ramirez; Daniel P Bailey; C Fitzhugh Yeatman; Joyce Yue; Harry V Wright; Jos Domen; Roberto R Rosato; Steven Grant; Krista Fischer-Stenger; John J Ryan
Journal:  Exp Hematol       Date:  2004-12       Impact factor: 3.084

View more
  53 in total

1.  Adipocytokines leptin and adiponectin function as mast cell activity modulators.

Authors:  Paulina Żelechowska; Ewa Brzezińska-Błaszczyk; Magdalena Wiktorska; Sylwia Różalska; Sebastian Wawrocki; Elżbieta Kozłowska; Justyna Agier
Journal:  Immunology       Date:  2019-07-10       Impact factor: 7.397

Review 2.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 3.  Mast Cell Interactions and Crosstalk in Regulating Allergic Inflammation.

Authors:  Tania E Velez; Paul J Bryce; Kathryn E Hulse
Journal:  Curr Allergy Asthma Rep       Date:  2018-04-17       Impact factor: 4.806

4.  Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis.

Authors:  Yuangang Liu; Zhiping Wang; Rachel De La Torre; Ashley Barling; Takahiro Tsujikawa; Noah Hornick; Jon Hanifin; Eric Simpson; Yun Wang; Emily Swanzey; Aaron Wortham; Hao Ding; Lisa M Coussens; Molly Kulesz-Martin
Journal:  J Invest Dermatol       Date:  2016-10-05       Impact factor: 8.551

Review 5.  Trained immunity in type 2 immune responses.

Authors:  Franziska Hartung; Julia Esser-von Bieren
Journal:  Mucosal Immunol       Date:  2022-09-05       Impact factor: 8.701

6.  IL-4-BATF signaling directly modulates IL-9 producing mucosal mast cell (MMC9) function in experimental food allergy.

Authors:  Sunil Tomar; Varsha Ganesan; Ankit Sharma; Chang Zeng; Lisa Waggoner; Andrew Smith; Chang H Kim; Paula Licona-Limón; Richard L Reinhardt; Richard A Flavell; Yui-Hsi Wang; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2020-10-15       Impact factor: 10.793

7.  Mesenchymal Stem Cells: a Potential Treatment Approach for Refractory Chronic Spontaneous Urticaria.

Authors:  Rabia Bilge Özgül Özdemir; Alper Tunga Özdemir; Cengiz Kırmaz; Ercüment Ovalı; Ercüment Ölmez; Hakan Kerem; Mustafa Kürşat Evrenos; Günnur Deniz
Journal:  Stem Cell Rev Rep       Date:  2020-10-22       Impact factor: 5.739

8.  BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice.

Authors:  Rajesh Kumar Radhakrishnan; Ramya Sivangala Thandi; Deepak Tripathi; Padmaja Paidipally; Madeline Kay McAllister; Sachin Mulik; Buka Samten; Ramakrishna Vankayalapati
Journal:  JCI Insight       Date:  2020-03-12

9.  Possible Regulation of bFGF Expression by Mast Cells in Osteoarthritis Patients with Obesity: A Cross-Sectional Study.

Authors:  Ken Takata; Kentaro Uchida; Shotaro Takano; Manabu Mukai; Gen Inoue; Hiroyuki Sekiguchi; Jun Aikawa; Masayuki Miyagi; Dai Iwase; Masashi Takaso
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-16       Impact factor: 3.168

10.  PAI1 mediates fibroblast-mast cell interactions in skin fibrosis.

Authors:  Neha Pincha; Edries Yousaf Hajam; Krithika Badarinath; Surya Prakash Rao Batta; Tafheem Masudi; Rakesh Dey; Peter Andreasen; Toshiaki Kawakami; Rekha Samuel; Renu George; Debashish Danda; Paul Mazhuvanchary Jacob; Colin Jamora
Journal:  J Clin Invest       Date:  2018-03-26       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.